NDC 0023-9177 Alphagan P
Brimonidine Tartrate Solution/ Drops Ophthalmic - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0023 - Allergan, Inc.
- 0023-9177 - Alphagan P
Product Packages
NDC Code 0023-9177-05
Package Description: 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER
Price per Unit: $39.79120 per ML
NDC Code 0023-9177-10
Package Description: 1 BOTTLE, DROPPER in 1 CARTON / 10 mL in 1 BOTTLE, DROPPER
Price per Unit: $39.64871 per ML
NDC Code 0023-9177-15
Package Description: 1 BOTTLE, DROPPER in 1 CARTON / 15 mL in 1 BOTTLE, DROPPER
Price per Unit: $39.82295 per ML
Product Details
What is NDC 0023-9177?
What are the uses for Alphagan P?
What are Alphagan P Active Ingredients?
- BRIMONIDINE TARTRATE 1.5 mg/mL - A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
Which are Alphagan P UNII Codes?
The UNII codes for the active ingredients in this product are:
- BRIMONIDINE TARTRATE (UNII: 4S9CL2DY2H)
- BRIMONIDINE (UNII: E6GNX3HHTE) (Active Moiety)
Which are Alphagan P Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- BORIC ACID (UNII: R57ZHV85D4)
- CALCIUM CHLORIDE (UNII: M4I0D6VV5M)
- MAGNESIUM CHLORIDE (UNII: 02F3473H9O)
- POTASSIUM CHLORIDE (UNII: 660YQ98I10)
- WATER (UNII: 059QF0KO0R)
- SODIUM BORATE (UNII: 91MBZ8H3QO)
- CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- HYDROCHLORIC ACID (UNII: QTT17582CB)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for Alphagan P?
- RxCUI: 861204 - brimonidine tartrate 0.1 % Ophthalmic Solution
- RxCUI: 861204 - brimonidine tartrate 1 MG/ML Ophthalmic Solution
- RxCUI: 861206 - Alphagan P 0.1 % Ophthalmic Solution
- RxCUI: 861206 - brimonidine tartrate 1 MG/ML Ophthalmic Solution [Alphagan]
- RxCUI: 861206 - Alphagan 1 MG/ML Ophthalmic Solution
Which are the Pharmacologic Classes for Alphagan P?
* Please review the disclaimer below.
Patient Education
Brimonidine Ophthalmic
Ophthalmic brimonidine is used to lower pressure in the eyes in patients who have glaucoma (high pressure in the eyes that may damage nerves and cause vision loss) and ocular hypertension (pressure in the eyes that is higher than normal but not high enough to cause vision loss). Brimonidine is in a class of drugs called alpha adrenergic agonists. Brimonidine works by decreasing the amount of fluid in the eyes.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".